SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

Share Price is delayed by 15 minutes
Get Live Data
929.50    -27.50 (-2.87%)
Bid:
926.00
Ask:
935.50
Spread: 9.50 (1.026%)
Market Cap: £838.07m
GAMA Live PriceLast checked at - London Stock Exchange

Intraday Gamma Communications Share Chart

Statement re Possible Offer

12 Jun 2026 15:28

RNS Number : 1788I
Oakley Capital Limited
12 June 2026
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

Β 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

FOR IMMEDIATE RELEASE

12 June 2026

Β 

Β 

No intention to make an offer for Gamma Communications plc ("Gamma")

On 15 May 2026, Gamma confirmed that it was in discussions with a consortium comprising Oakley Capital Limited ("Oakley") and Giacom Limited ("Giacom").

It has since been clarified to Gamma that Oakley was acting as the potential offeror and that Giacom was in preliminary discussions with Oakley regarding a possible purchase of some of the assets of Gamma (but was not acting in a consortium or acting in concert with Oakley).

Oakley confirms that it is not intending to make an offer for Gamma.

This is a statement to which Rule 2.8 of the Code applies.

Under Note 2 on Rule 2.8 of the Code, Oakley reserves the right to set the restrictions in Rule 2.8 aside in the following circumstances:

a. with the agreement of the board of Gamma;

b. if a third party, including the consortium comprising Providence Equity Partners L.L.C. and Epiris LLP, announces a firm intention to make an offer for Gamma;

c. if Gamma announces a Rule 9 waiver (see Note 1 of the Notes on Dispensations from Rule 9) or a reverse takeover (as defined in the Code); and

d. if there has been a material change of circumstances (as determined by the Panel on Takeovers and Mergers).

The Panel on Takeovers and Mergers has agreed that the restrictions set out in Rule 2.8 of the Code resulting from this announcement do not apply to Giacom as it was not acting in a consortium or acting in concert with Oakley.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
OFDZLLFFQQLFBBQ
Date   Source Headline
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:02 amRNSShare buyback programme
25th Mar 20247:01 amRNSFinal Results
25th Mar 20247:00 amRNSBoard Change and Committee Composition
22nd Mar 20245:20 pmRNSHolding(s) in Company
14th Mar 20247:30 amRNSDirector/PDMR Shareholding
1st Mar 20242:31 pmRNSTotal Voting Rights
14th Feb 20248:38 amRNSDirector/PDMR Shareholding
13th Feb 20248:00 amRNSSite visit for investors
1st Feb 20241:49 pmRNSTotal Voting Rights
17th Jan 20243:51 pmRNSHolding(s) in Company
16th Jan 20247:00 amRNSScheduled Trading Update
15th Jan 20244:46 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:24 amRNSTotal Voting Rights
28th Dec 20234:10 pmRNSHolding(s) in Company
21st Dec 20235:34 pmRNSHolding(s) in Company
21st Dec 20235:33 pmRNSHolding(s) in Company
13th Dec 20235:35 pmRNSDirector/PDMR Shareholding
13th Dec 202312:34 pmRNSIssue of Equity
5th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20234:13 pmRNSHolding(s) in Company
15th Nov 202310:31 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSBlock listing Interim Review
1st Nov 202311:13 amRNSTotal Voting Rights
13th Oct 20233:59 pmRNSDirector/PDMR Shareholding
2nd Oct 20232:34 pmRNSTotal Voting Rights
14th Sep 20234:12 pmRNSIssue of Equity
14th Sep 20237:00 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSHalf-year Report
1st Sep 20237:00 amRNSTotal Voting Rights
25th Aug 20232:25 pmRNSHolding(s) in Company
15th Aug 20234:24 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:00 amRNSTrading Statement
1st Aug 20237:00 amRNSTotal Voting Rights
13th Jul 20232:04 pmRNSDirector/PDMR Shareholding
3rd Jul 202312:11 pmRNSDirector/PDMR Shareholding
3rd Jul 202310:43 amRNSTotal Voting Rights
13th Jun 20235:03 pmRNSDirector/PDMR Shareholding
9th Jun 202312:35 pmRNSDirector/PDMR Shareholding
1st Jun 20232:19 pmRNSTotal Voting Rights - Replacement
1st Jun 202312:17 pmRNSTotal Voting Rights
30th May 202310:05 amRNSBlock Listing Application
25th May 20237:00 amRNSAppointment of Chair
23rd May 20234:12 pmRNSDirector/PDMR Shareholding
17th May 20235:08 pmRNSCommittee Composition
17th May 20234:25 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Trading update
15th May 202311:46 amRNSDirector/PDMR Shareholding
10th May 20237:00 amRNSDirector/PDMR Shareholding
9th May 20239:44 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.